tiprankstipranks
Trending News
More News >
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market

Kiniksa Pharmaceuticals (KNSA) Revenue

Compare
550 Followers

Kiniksa Pharmaceuticals Revenue

Kiniksa Pharmaceuticals had a revenue of 202.13M in the quarter ending Dec 31, 2025, with 11.76%. This bring the company's revenue in the last twelve months to 677.56M, Decreased 13.31%. In the fiscal year ending Dec 31, 2025, Kiniksa Pharmaceuticals had annual revenue of 677.56M with 60.09% growth.
Revenue (ttm)
677.56M
Revenue Growth
55.68%
P/S Ratio
5.31
Revenue/Employee
$2,150,997
Employees
315
Market Cap
$3.60B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
677.56M254.32M+60.09%
Dec 31, 2024
423.24M152.98M+56.60%
Dec 31, 2023
270.26M50.08M+22.74%
Dec 31, 2022
220.18M181.64M+471.24%
Dec 31, 2021
38.54M+∞%
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017